Report Studies
• The global Cephalexine market was valued at US$ 158.5 million in 2023 and is projected to reach US$ 195.4 million by 2030, at a CAGR of 3.1% during the forecast period.
• Cephalosporins are a class of antibiotics used to treat a wide range of bacterial infections. Factors such as increasing prevalence of infectious diseases, rising antimicrobial resistance, and growing demand for effective antibiotics are driving market growth. The market is highly competitive, with several pharmaceutical companies manufacturing and marketing cephalosporin drugs. However, challenges such as the emergence of new drug-resistant strains, strict regulatory requirements, and the availability of alternative treatment options may hinder market growth.
Email: help@24marketreports.com Call: +1(646)-781-7170 (Int'l)